Vericiguat reduces atrial fibrillation recurrence by alleviating myocardial fibrosis via the TGF-β1/Smad2/3 pathway

• XiaoLin Sun ,

  Contributed equally to this work with: XiaoLin Sun, Yawen Sheng, Pei Xu

  Roles Data curation, Formal analysis, Funding acquisition, Writing – original draft

  Affiliation Department of Cardiology, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, Jiangsu, The People’s Republic of China

  ⨯
• Yawen Sheng ,

  Contributed equally to this work with: XiaoLin Sun, Yawen Sheng, Pei Xu

  Roles Software

  Affiliation Department of Cardiology, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, Jiangsu, The People’s Republic of China

  ⨯
• Pei Xu ,

  Contributed equally to this work with: XiaoLin Sun, Yawen Sheng, Pei Xu

  Roles Conceptualization, Data curation, Methodology, Writing – original draft

  Affiliation Department of Hematology, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, Jiangsu, The People’s Republic of China

  ⨯
• Qian Peng,

  Roles Data curation, Formal analysis, Investigation, Methodology, Project administration

  Affiliation Nanjing University of Chinese Medicine, Nanjing, Jiangsu, The People’s Republic of China

  ⨯
• Zhongbao Ruan

  Roles Funding acquisition, Investigation, Resources, Supervision, Writing – review & editing

  * E-mail: tzcardiac@163.com

  Affiliation Department of Cardiology, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, Jiangsu, The People’s Republic of China

  https://orcid.org/0009-0006-8173-8278

  ⨯